Indian Journal of Endocrinology and Metabolism

BRIEF COMMUNICATION
Year
: 2013  |  Volume : 17  |  Issue : 5  |  Page : 913--916

Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment


Anu Gupta1, Yashdeep Gupta2 
1 Department of Neurology, PGIMER, Chandigarh, India
2 Department of Medicine, Government Medical College and Hospital, Chandigarh, India

Correspondence Address:
Yashdeep Gupta
Department of Medicine, Government Medical College and Hospital, Chandigarh - 160 030
India

Glucocorticoid-induced myopathy is the most common type of drug-induced myopathy. Nearly 60% of patients with Cushing«SQ»s syndrome have muscle weakness. Glucocorticoid-induced muscle atrophy affects mainly fast-twitch glycolytic muscle fibers (type IIb fibers). This brief review will discuss the pathophysiology behind glucocorticoid-induced myopathy, along with diagnostic features and treatment.


How to cite this article:
Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment.Indian J Endocr Metab 2013;17:913-916


How to cite this URL:
Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocr Metab [serial online] 2013 [cited 2021 Apr 13 ];17:913-916
Available from: https://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=5;spage=913;epage=916;aulast=Gupta;type=0